Cited by 70Extracellular vesicles in diseaseNanoparticle-Based Drug DeliveryCaveolin-1 and cellular processes

Extracellular vesicles: translational challenges and opportunities

Clemmens, Hannah, Lambert, Daniel W.·2018·Biochemical Society Transactions

Abstract

Extracellular vesicles (EVs) are a heterogeneous group of small lipid-enclosed structures with myriad roles in physiology and disease. The recent surge of interest in EVs has led to greater understanding of their biology and appreciation of how they might be utilised as diagnostic and therapeutic tools. There remain, however, a number of challenges that must be overcome before EVs may be used routinely in the clinic. In this review we will discuss the translational potential of EVs and the current technologies available to isolate, purify and analyse EVs and their contents.

Integrity signals

Registry

Crossref · 10.1042/bst20180112

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • EVs often lack the long-lasting stability, potency, and targeting precision needed for effective disease diagnosis and treatment.

    “While EVs offer promising potential for CNS theranostics, EVs often lack the long-lasting stability, potency, and targeting precision needed for effective disease diagnosis and treatment [227].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Clemmens, H., & Lambert, D. W.
Affiliations
University of Sheffield (GB)
Corresponding author
Clemmens, Hannah
Venue
Biochemical Society Transactions
Published
2018-09-21
Volume
46
Issue
5
Pages
1073-1082
ISSN
  • 0300-5127 (ISSN-L)
  • 1470-8752
OpenAlex
W2890650452
Cited by
70
References
8
Citations by year
2026: 1 · 2025: 9 · 2024: 16 · 2023: 18 · 2022: 9 · 2021: 7 · 2020: 6 · 2019: 4
FWCI
0.42
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemical Society Transactions (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
Keywords
extracellular vesicles, translational medicine, EV isolation, EV purification, diagnostic biomarkers, therapeutic applications
MeSH terms
Extracellular Vesicles, Animals, Cell Communication, Extracellular Matrix, Heart Diseases, Humans, Lipids, Models, Biological, Neoplasms, Nervous System Diseases, Phagocytosis, Biomarkers, Drug Delivery Systems, Apoptosis, Cell Transplantation, Proteomics, Exosomes, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review